FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:2544-2546 June 17, 2004 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Kainer, M. A. PubMed Citation

The 2003 Institute of Medicine report Microbial Threats to Health: Emergence, Detection, and Response lists "advances in medical technologies, such as blood transfusions and organ transplants," as one reason for "new or enhanced microbial threats." Musculoskeletal allografts represent a form of technology that poses a risk of transmission of infection, and their use is increasing. In 2002, approximately 1 million such allografts were distributed in the United States. Unlike solid-organ allografts, most musculoskeletal allografts are used for life-enhancing rather than life-saving procedures, and as the report by Kainer et al. in this issue of the Journal (pages 2564–2571) demonstrates, their . . . [Full Text of this Article]

Source Information

From the Division of Infectious Diseases, Department of Internal Medicine (R.P., A.T.), and the Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology (R.P.), Mayo Clinic College of Medicine, Rochester, Minn.

This article has been cited by other articles:

• Mroz, T. E., Joyce, M. J., Steinmetz, M. P., Lieberman, I. H., Wang, J. C. (2008). Musculoskeletal Allograft Risks and Recalls in the United States. J Am Acad Orthop Surg 16: 559-565 [Abstract] [Full Text]  
• (2004). Musculoskeletal Allografts: Beware of Clostridium Infections. JWatch Infect. Diseases 2004: 7-7 [Full Text]